About: http://webisa.webdatacommons.org/217532849

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Exenatide, the active agent in ITCA 650, has been approved in the U.S., Europe and other markets and is currently marketed as a twice-daily self-injection therapy for type 2 diabetes.
http://www.w3.org/ns/prov#wasQuotedFrom	prnewswire.com